BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Udagawa H. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer. Ann Gastroenterol Surg 2020;4:324-30. [PMID: 32724875 DOI: 10.1002/ags3.12338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee TH, Kim HJ, Kim BH, Kang CH, Keam B, Moon HJ, Seong YW, Kim S, Hsieh YJ. Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/5635071] [Reference Citation Analysis]
2 Urabe M, Ueno M, Udagawa H. Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: Experiences related to esophageal cancer surgery. Head Neck 2020;42:3098-9. [PMID: 32761686 DOI: 10.1002/hed.26392] [Reference Citation Analysis]
3 Yan Z, Xu X, Lu J, You Y, Xu J, Xu T. Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02243-8] [Reference Citation Analysis]
4 Imai T, Tanaka Y, Sato Y, Mase J, Suetsugu T, Fukada M, Yasufuku I, Iwata Y, Mori R, Imai H, Kato T, Okumura N, Matsuhashi N, Takahashi T, Futamura M, Yoshida K. The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis. Indian J Surg Oncol 2021;:1-9. [PMID: 34483594 DOI: 10.1007/s13193-021-01419-0] [Reference Citation Analysis]